13 Best Long Term Growth Stocks to Invest in Right Now
She said that the equity market is looking beyond tariffs instead of focusing on them.
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 5,438,446 | $4,491,667,635 | +4% | 1.94% |
| 2. | 1,935,700 | $1,598,713,987 | -10% | 0.3% | |
| 3. | GQG Partners Rajiv Jain | 1,829,453 | $1,510,963,352 | -60% | 2.41% |
| 4. | 1,649,500 | $1,362,338,545 | -12% | 0.26% | |
| 5. | Tiger Global Management LLC Chase Coleman And Feroz Dewan | 1,334,960 | $1,102,556,814 | +2% | 4.15% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $304.19 | 656 | $199,548.64 | 62,857 | 2022-08-12 | Filing | |
| $246.78 | 202 | $49,849.56 | 15,436 | 2022-03-01 | Filing | |
| $182.99 | 546 | $99,912.54 | 61,195 | 2021-04-30 | Filing | |
| $182.74 | 820 | $149,846.80 | 60,649 | 2021-04-30 | Filing | |
| $108.84 | 1,000 | $108,840.00 | 22,043 | 2019-10-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $716.41 | 1,000 | $716,410.00 | 4,840 | 2025-05-27 | Filing | |
| $749.24 | 1,250 | $936,550.00 | 27,510 | 2025-05-14 | Filing | |
| $818.24 | 1,000 | $818,240.00 | 5,840 | 2025-03-13 | Filing | |
| $934.89 | 812 | $759,129.87 | 96,016,978 | 2025-03-03 | Filing | |
| $933.74 | 3,997 | $3,732,138.80 | 96,017,790 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 101,288,687 | $83,655,339,481 | 43.8% | |
| 2. | 96,016,978 | $79,301,382,300 | 100% | |
| 3. | 79,224,392 | $65,432,217,584 | 1.18% | |
| 4. | 65,691,973 | $54,255,657,747 | 1.14% | |
| 5. | 34,437,950 | $28,442,647,285 | 1.17% |
News See All
Eli Lilly & Co. (LLY) is Recovering from the Period of Volatility
Macquarie Asset Management, an investment management company, released its “Macquarie Large Cap Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Eli Lilly Mounjaro Sees Strong Reception in India, Rising Demand Amid Obesity, Diabetes Rates
Eli Lilly and Company (NYSE:LLY) is one of the best Fortune 500 stocks to buy according to billionaires.
Eli Lilly (LLY) Retains $1,100 Price Target at Bernstein Ahead of Diabetes Conference
Eli Lilly & Company (NYSE:LLY) is one of billionaire Stan Druckenmiller’s top stock picks with huge upside potential.
12 Best Fortune 500 Stocks to Buy According to Billionaires
On June 18, Jason Hunter, JPMorgan's head of technical strategy, joined CNBC's 'Closing Bell' to discuss how he believes that there's a bias for the market to correct over the short term.
Jim Cramer Reveals Potential US Rare Earth Trump Card & Discusses These 11 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed public interest in nuclear power stocks.
What Makes Eli Lilly and Company (LLY) a Lucrative Investment?
Baron Funds, an investment management company, released its “Baron Fifth Avenue Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Billionaire Stan Druckenmiller's 10 Stock Picks with Huge Upside Potential
Stanley Druckenmiller, an American billionaire investor, is the founder of Duquesne Capital.
Adam Parker of Trivariate Research Recommends Eli Lilly’s Dividend as a Defensive Play
According to Adam Parker, founder of Trivariate Research, investors aiming for a defensive approach might want to look at select dividend-paying stocks.
UBS Maintains Price Target on Eli Lilly (LLY) Despite CVS Shift to Wegovy
Eli Lilly and Company (NYSE:LLY) is one of the 15 best stocks to invest in for an 18 year old.